Clinical and laboratory characteristics of children with leukemia: a 34-year single-center experience

Hüseyin Bahadır Şenol1, Özlem Tüfekçi Gürocak2, Şebnem Yılmaz2

  • 1Department of Pediatric Neurology, Faculty of Medicine, Dokuz Eylül University, İzmir, Türkiye.

PubMed

Insights

Early leukemia diagnosis in children is crucial. Fatigue, fever, and bone pain are common symptoms, but signs like lymphadenopathy can speed up diagnosis, improving outcomes.

Area of Science:

  • Pediatric Oncology
  • Hematology
  • Diagnostic Medicine

Background:

  • Leukemia is the most common childhood cancer, often presenting with vague symptoms that delay diagnosis.
  • Timely diagnosis and referral are vital for improving outcomes in pediatric leukemia patients.

Purpose of the Study:

  • To assess clinical and laboratory features of pediatric acute and relapsed leukemia.
  • To identify factors contributing to delayed diagnosis in children with leukemia.

Main Methods:

  • Retrospective analysis of 378 pediatric leukemia patients diagnosed between 1986 and 2020.
  • Defined early diagnosis as within 20 days of symptom onset.

Main Results:

  • Fatigue, fever, and bone pain were most common symptoms; anemia and thrombocytopenia were frequent lab findings.
  • Late diagnosis associated with bone/joint pain, mucosal bleeding, pallor; early diagnosis linked to lymphadenopathy, bone tenderness, low hemoglobin.
  • Relapsed leukemia cases showed more abnormal blood counts and neurological symptoms.

Conclusions:

  • Common presenting symptoms include fatigue, fever, and bone pain; key physical findings are hepatomegaly, splenomegaly, and lymphadenopathy.
  • Specific symptoms (bone/joint pain, bleeding, pallor) correlate with delayed diagnosis, while others (lymphadenopathy, bone tenderness) aid early recognition.
Abstract

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
910
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
1.8K